Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Observational Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent Endoscopic Resection Surgery for Bladder Cancer (TURBK).

NCT06167356 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06167356
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06167356 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Observational Study on the Occurrence of Possible Relapses and on the Quality of Life in Patients Who Underwent Endoscopic Resection Surgery for Bladder Cancer (TURBK).
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
November 27, 2013
Completion date
November 27, 2063
Enrollment
20,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, bladder cancer recurrent, bladder cancer stage i, with cancer in situ, bladder disease, bladder neoplasm, bladder urothelial carcinoma, bladder urothelial carcinoma in situ, bladder urothelial dysplasia, non muscle invasive bladder cancer, non-muscle invasive bladder neoplasms, non-muscle invasive bladder urothelial carcinoma